Chemical composition, saccharification yield, and the potential of the green seaweed Ulva pertusa

The green seaweed Ulva: tomorrow's "wheat of the sea" in foods, feeds, nutrition, and biomaterials

Ulva, a genus of green macroalgae commonly known as sea lettuce, has long been recognized for its nutritional benefits for food and feed. As the demand for sustainable food and feed sources continues to grow, so does the interest in alternative, plant-based protein sources. With its abundance along coastal waters and high protein content, Ulva spp. have emerged as promising candidates. While the use of Ulva in food and feed has its challenges, the utilization of Ulva in other industries, including in biomaterials, biostimulants, and biorefineries, has been growing. This review aims to provide a comprehensive overview of the current status, challenges and opportunities associated with using Ulva in food, feed, and beyond. Drawing on the expertise of leading researchers and industry professionals, it explores the latest knowledge on Ulva's nutritional value, processing methods, and potential benefits for human nutrition, aquaculture feeds, terrestrial feeds, biomaterials, biostimulants and biorefineries. In addition, it examines the economic feasibility of incorporating Ulva into aquafeed. Through its comprehensive and insightful analysis, including a critical review of the challenges and future research needs, this review will be a valuable resource for anyone interested in sustainable aquaculture and Ulva's role in food, feed, biomaterials, biostimulants and beyond.

Seaweed Exhibits Therapeutic Properties against Chronic Diseases: An Overview

Seaweeds or marine macroalgae are known for producing potentially bioactive substances that exhibit a wide range of nutritional, therapeutic, and nutraceutical properties. These compounds can be applied to treat chronic diseases, such as cancer, cardiovascular disease, osteoporosis, neurodegenerative diseases, and diabetes mellitus. Several studies have shown that consumption of seaweeds in Asian countries, such as Japan and Korea, has been correlated with a lower incidence of chronic diseases. In this study, we conducted a review of published papers on seaweed consumption and chronic diseases. We used the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) method for this study. We identified and screened research articles published between 2000 and 2021. We used PubMed and ScienceDirect databases and identified 107 articles. This systematic review discusses the potential use of bioactive compounds of seaweed to treat chronic diseases and identifies gaps where further research in this field is needed. In this review, the therapeutic and nutraceutical properties of seaweed for the treatment of chronic diseases such as neurodegenerative diseases, obesity, diabetes, cancer, liver disease, cardiovascular disease, osteoporosis, and arthritis were discussed. We concluded that further study on the identification of bioactive compounds of seaweed, and further study at a clinical level, are needed.

Recent Advances in Bioutilization of Marine Macroalgae Carbohydrates: Degradation, Metabolism, and Fermentation

Marine macroalgae are considered renewable natural resources due to their high carbohydrate content, which gives better utilization value in biorefineries and higher value conversion than first- and second-generation biomass. However, due to the diverse composition, complex structure, and rare metabolic pathways of macroalgae polysaccharides, their bioavailability needs to be improved. In recent years, enzymes and pathways related to the degradation and metabolism of macroalgae polysaccharides have been continuously developed, and new microbial fermentation platforms have emerged. Aiming at the bioutilization and transformation of macroalgae resources, this review describes the latest research results from the direction of green degradation, biorefining, and metabolic pathway design, including summarizing the the latest biorefining technology and the fermentation platform design of agarose, alginate, and other polysaccharides. This information will provide new research directions and solutions for the biotransformation and utilization of marine macroalgae.

Levulinic Acid Production from Macroalgae: Production and Promising Potential in Industry

The development of macroalgal biorefinery products as an alternative source of renewable fuels is an opportunity to solve the dependence on fossil fuels. Macroalgae is a potential biomass that can be developed as a raw material for producing platform chemicals such as levulinic acid (LA). In the industrial sector, LA is among the top 12 biomass-derived feedstocks designated by the U.S. Department of Energy as a high-value chemical. Several studies have been conducted on the production of LA from terrestrial-based biomass, however, there is still limited information on its production from macroalgae. The advantages of macroalgae over terrestrial and other biomasses include high carbohydrate and biomass production, less cultivation cost, and low lignin content. Therefore, this study aims to investigate the potential and challenge of producing LA from macroalgae in the industrial sector and determine its advantages and disadvantages compared with terrestrial biomass in LA production. In this study, various literature sources were examined using the preferred reporting items for systematic reviews and meta-analyses (PRISMA) method to identify, screen, and analyze the data of the published paper. Despite its advantages, there are some challenges in making the production of levulinic acid from macroalgae feasible for development at the industrial scale. Some challenges such as sustainability of macroalgae, the efficiency of pretreatment, and hydrolysis technology are often encountered during the production of levulinic acid from macroalgae on an industrial scale.

DOC dynamics and bacterial community succession during long-term degradation of Ulva prolifera and their implications for the legacy effect of green tides on refractory DOC pool in seawater

Under climate warming and coastal eutrophication, outbreaks of green tides have increased in recent decades; e.g., the world's largest green tide caused by Ulva prolifera has occurred in the Yellow Sea for 13 consecutive years. The massive assemblage of macroalgae absorbs large amounts of atmospheric CO₂ and converts it into biomass. After the green tide, millions of tons of the macroalgal biomass sink to the seabed to be degraded eventually; this inevitably has a significant impact on the coastal organic carbon pool and microbial community. However, this impact is poorly understood. Here, the degradation of Ulva prolifera over 520 days revealed that relatively sufficient degradation of the macroalgae occurred at ca. 7 months. The rapid release of dissolved organic carbon (DOC) mainly occurred in the first week, which not only increased the size and diversity of the DOC pool in a short time but also promoted the rapid growth of bacteria and led to hypoxia and acidification of the seawater. After that, the labile portion of DOC was gradually used up by bacteria within one month, while the degradation of semi-labile or semi-refractory DOC occurred in half a year. The remaining DOC existed in the form of refractory DOC (RDOC), resisting bacterial consumption and remaining stable for 10 months. During the long-term degradation process, bacterial community structure and metabolic function showed obvious successional characteristics, driving the gradual transformation of DOC from labile to refractory through the microbial carbon pump mechanism. After the long-term degradation, the remaining RDOC accounted for approximately 1.6% of the macroalgal carbon biomass. As RDOC can maintain long-term stability, we propose that the frequent outbreaks of green tides not only affect microbial processes but also may have an important cumulative effect on the coastal RDOC pool.

Enhancement of bioethanol production from Gracilaria verrucosa by Saccharomyces cerevisiae through the overexpression of SNR84 and PGM2

A total monosaccharide concentration of 47.0 g/L from 12% (w/v) Gracilaria verrucosa was obtained by hyper thermal acid hydrolysis with 0.2 M HCl at 140°C for 15 min and enzymatic saccharification with CTec2. To improve galactose utilization, we overexpressed two genes, SNR84 and PGM2, in a Saccharomyces cerevisiae CEN-PK2 using CRISPR/Cas-9. The overexpression of both SNR84 and PGM2 improved galactose utilization and ethanol production compared to the overexpression of each gene alone. The overexpression of both SNR84 and PGM2 and of PGM2 and SNR84 singly in S. cerevisiae CEN-PK2 Cas9 produced 20.0, 18.5, and 16.5 g/L ethanol with ethanol yield (Y_EtOH) values of 0.43, 0.39, and 0.35, respectively. However, S. cerevisiae CEN-PK2 adapted to high concentration of galactose consumed galactose completely and produced 22.0 g/L ethanol at a Y_EtOH value of 0.47. The overexpression of both SNR84 and PGM2 increased the transcriptional levels of GAL and regulatory genes; however, the transcriptional levels of these genes were lower than those in S. cerevisiae adapted to high galactose concentrations.

Seaweed Bioethanol Production: A Process Selection Review on Hydrolysis and Fermentation

The rapid depletion and environmental concerns associated with the use of fossil fuels has led to extensive development of biofuels such as bioethanol from seaweeds. The long-term prospect of seaweed bioethanol production however, depends on the selection of processes in the hydrolysis and fermentation stages due to their limiting effect on ethanol yield. This review explored the factors influencing the hydrolysis and fermentation stages of seaweed bioethanol production with emphasis on process efficiency and sustainable application. Seaweed carbohydrate contents which are most critical for ethanol production substrate selection were 52 ± 6%, 55 ± 12% and 57 ± 13% for green, brown and red seaweeds, respectively. Inhibitor formation and polysaccharide selectivity were found to be the major bottlenecks influencing the efficiency of dilute acid and enzymatic hydrolysis, respectively. Current enzyme preparations used, were developed for starch-based and lignocellulosic biomass but not seaweeds, which differs in polysaccharide composition and structure. Also, the identification of fermenting organisms capable of converting the heterogeneous monomeric sugars in seaweeds is the major factor limiting ethanol yield during the fermentation stage and not the SHF or SSF pathway selection. This has resulted in variations in bioethanol yields, ranging from 0.04 g/g DM to 0.43 g/g DM.